Copyright © 2001 by the European Society of Cardiology.
The interleukin-6 174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men
a Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Royal Free and University College London Medical School, London, U.K.
b MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Medical College of St. Bartholomew's Hospital, London, U.K.
revised February 20, 2001; accepted February 21, 2001
Abstract
Aims Inflammation is a key component of coronary heart disease, and genes coding for cytokines are candidates for predisposing to coronary heart disease risk. We have examined the effect of two polymorphisms (174G>C and 572G>C) in the promoter of the interleukin-6 (IL-6) gene on risk of coronary heart disease, and on intermediate risk traits including fibrinogen and systolic blood pressure, in 2751 middle-aged healthy U.K. men.
Results The 174C allele (frequency 0·43, 95% CI 0·420·44) was not associated with significant effects on fibrinogen levels, but was associated with a significantly (P=0·007) higher systolic blood pressure (mean mmHg (95% CI): GG=135·5 (134·3136·7); GC=137·9 (136·9138·9); CC= 138·0 (136·3139·8)). This effect was of similar magnitude in smokers and non-smokers, and was greater in men in the top two tertiles of body mass index (>24·86kg.m2) than in those in the bottom tertile. Compared to those with the genotype GG, men carrying the 174C allele had a relative risk of coronary heart disease of 1·54 (95% CI 1·02·23, P=0·048) and this effect was greatest in smokers (compared to GG non-smokers, RR 2·66, CI 1·644·32). These effects remained statistically significant after adjusting for classical risk factors including blood pressure (P=0·04). The 572C allele (frequency 0·05, 0·040·06) was not associated with a significant effect on blood pressure, fibrinogen or relative risk of coronary heart disease. In a subset of the genotyped men (n=494), carriers of the 174C allele had higher levels of C-reactive protein than non-carriers.
Conclusions These data confirm the importance of the inflammatory system in the development of coronary heart disease. They suggest that, at least in part, the effect of the IL-6 174G>C polymorphism on blood pressure is likely to be operating through inflammatory mechanisms, but the genotype effect on coronary heart disease risk is largely unexplained by its effect on blood pressure. The molecular mechanisms whereby genetically determined differences in plasma levels of IL-6 are having these effects remain to be determined.
Key Words: Interleukin-6, polymorphisms, systolic blood pressure, inflammation, prospective study, smoking
f1 Correspondence: Professor Steve Humphries, Division of Cardiovascular Genetics, Department of Medicine, UCL Medical School, Rayne Institute, University Street, London WC1E 6JJ, U.K.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Aker, C. Bantis, P. Reis, N. Kuhr, C. Schwandt, B. Grabensee, P. Heering, and K. Ivens Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2847 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vlachopoulos, D. Terentes-Printzios, I. Dima, K. Aznaouridis, and C. Stefanadis Polymorphisms of Inflammatory Markers/Mediators and Arterial Stiffness Hypertension, June 1, 2009; 53(6): e39 - e39. [Full Text] [PDF] |
||||
![]() |
V. F. Panoulas, K. M. J. Douglas, J. P. Smith, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, and G. D. Kitas Transforming growth factor-{beta}1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis Rheumatology, February 1, 2009; 48(2): 113 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corella, J. I. Gonzalez, M. Bullo, P. Carrasco, O. Portoles, J. Diez-Espino, M. I. Covas, V. Ruiz-Gutierrez, E. Gomez-Gracia, F. Aros, et al. Polymorphisms Cyclooxygenase-2 -765G>C and Interleukin-6 -174G>C Are Associated with Serum Inflammation Markers in a High Cardiovascular Risk Population and Do Not Modify the Response to a Mediterranean Diet Supplemented with Virgin Olive Oil or Nuts J. Nutr., January 1, 2009; 139(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, D. K. Arnett, P. Perez-Martinez, L. D. Parnell, C.-Q. Lai, J. M. Peacock, J. E. Hixson, M. Y. Tsai, R. J. Straka, P. N. Hopkins, et al. The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study,boxs J. Lipid Res., August 1, 2008; 49(8): 1839 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trichopoulou, N. Yiannakouris, C. Bamia, V. Benetou, D. Trichopoulos, and J. M. Ordovas Genetic Predisposition, Nongenetic Risk Factors, and Coronary Infarct Arch Intern Med, April 28, 2008; 168(8): 891 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Liao, J.-T. Lin, C.-Y. Wu, S.-P. Huang, M.-T. Lin, A. S.-H. Wu, Y.-J. Huang, and M.-S. Wu Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma Clin. Cancer Res., January 15, 2008; 14(2): 428 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H A Malik, F Jury, A Bayat, W E R Ollier, and P R Kay Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor Ann Rheum Dis, August 1, 2007; 66(8): 1116 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Humphries, J. A. Cooper, P. J. Talmud, and G. J. Miller Candidate Gene Genotypes, Along with Conventional Risk Factor Assessment, Improve Estimation of Coronary Heart Disease Risk in Healthy UK Men Clin. Chem., January 1, 2007; 53(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF] |
||||
![]() |
L Morgan, J Cooper, H Montgomery, N Kitchen, and S E Humphries The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(8): 915 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, N. Metoki, H. Yoshida, K. Satoh, S. Ichihara, K. Kato, T. Kameyama, K. Yokoi, H. Matsuo, T. Segawa, et al. Genetic Risk for Ischemic and Hemorrhagic Stroke Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1920 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. C. de Geus Genetic pleiotropy in depression and coronary artery disease. Psychosom Med, March 1, 2006; 68(2): 185 - 186. [Full Text] [PDF] |
||||
![]() |
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med, March 1, 2006; 68(2): 187 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, Y. Berthier-Schaad, M. D. Fallin, N. E. Fink, R. P. Tracy, M. J. Klag, M. W. Smith, and J. Coresh IL-6 Haplotypes, Inflammation, and Risk for Cardiovascular Disease in a Multiethnic Dialysis Cohort J. Am. Soc. Nephrol., March 1, 2006; 17(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P.S. Sie, F. A. Sayed-Tabatabaei, H.-H. S. Oei, A. G. Uitterlinden, H. A.P. Pols, A. Hofman, C. M. van Duijn, and J. C.M. Witteman Interleukin 6 -174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease: Results from the Rotterdam Study and a Meta-Analysis Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 212 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bruunsgaard Physical activity and modulation of systemic low-level inflammation J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leibovici, H. B. Grossman, C. P. Dinney, R. E. Millikan, S. Lerner, Y. Wang, J. Gu, Q. Dong, and X. Wu Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and Survival J. Clin. Oncol., August 20, 2005; 23(24): 5746 - 5756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Shaw, A. A. Vaporciyan, X. Wu, T. M. King, M. R. Spitz, J. B. Putnam, and B. F. Dickey Inflammatory Gene Polymorphisms Influence Risk of Postoperative Morbidity After Lung Resection Ann. Thorac. Surg., May 1, 2005; 79(5): 1704 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weger, I. Steinbrugger, A. Haas, W. Marz, Y. El-Shabrawi, W. Weger, O. Schmut, and W. Renner Role of the Interleukin-6 -174 G>C Gene Polymorphism in Retinal Artery Occlusion Stroke, February 1, 2005; 36(2): 249 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huber, C. Grimm, S. Jirecek, R. Zeillinger, K. Heim, P. Husslein, and L. Hefler An lnterleukin-6 Gene Promoter Polymorphism and Unexplained Late Intrauterine Fetal Death: A Multicenter Study Reproductive Sciences, January 1, 2005; 12(1): 33 - 36. [Abstract] [PDF] |
||||
![]() |
M. Bennermo, C. Held, S. Stemme, C.-G. Ericsson, A. Silveira, F. Green, and P. Tornvall Genetic Predisposition of the Interleukin-6 Response to Inflammation: Implications for a Variety of Major Diseases? Clin. Chem., November 1, 2004; 50(11): 2136 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Freeman, F. McManus, E. A. Brown, L. Cherry, J. Norrie, J. E. Ramsay, P. Clark, I. D. Walker, N. Sattar, and I. A. Greer Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia Hypertension, November 1, 2004; 44(5): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kunicki, A. B. Federici, D. R. Salomon, J. A. Koziol, S. R. Head, T. S. Mondala, J. D. Chismar, L. Baronciani, M. T. Canciani, and I. R. Peake An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees Blood, October 15, 2004; 104(8): 2359 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Harding, S. Dhamrait, A. Whitelaw, S. E. Humphries, N. Marlow, and H. E. Montgomery Does Interleukin-6 Genotype Influence Cerebral Injury or Developmental Progress After Preterm Birth? Pediatrics, October 1, 2004; 114(4): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J McCarthy, A Parker, R Salem, D J Moliterno, Q Wang, E F Plow, S Rao, G Shen, W J Rogers, L K Newby, et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes J. Med. Genet., May 1, 2004; 41(5): 334 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Humphries, P. M. Ridker, and P. J. Talmud Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation? Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 628 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. DeMichele, A.-M. Martin, R. Mick, P. Gor, L. Wray, M. Klein-Cabral, G. Athanasiadis, T. Colligan, E. Stadtmauer, and B. Weber Interleukin-6 -174G->C Polymorphism Is Associated with Improved Outcome in High-Risk Breast Cancer Cancer Res., November 15, 2003; 63(22): 8051 - 8056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Harding, S. Dhamrait, A. Millar, S. Humphries, N. Marlow, A. Whitelaw, and H. Montgomery Is Interleukin-6 -174 Genotype Associated With the Development of Septicemia in Preterm Infants? Pediatrics, October 1, 2003; 112(4): 800 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M.L. Chapman, J. P. Beilby, S. E. Humphries, L. J. Palmer, P. L. Thompson, and J. Hung Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population Eur. Heart J., August 2, 2003; 24(16): 1494 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Landi, V. Moreno, L. Gioia-Patricola, E. Guino, M. Navarro, J. de Oca, G. Capella, and F. Canzian Association of Common Polymorphisms in Inflammatory Genes Interleukin (IL)6, IL8, Tumor Necrosis Factor {alpha}, NFKB1, and Peroxisome Proliferator-activated Receptor {gamma} with Colorectal Cancer , Cancer Res., July 1, 2003; 63(13): 3560 - 3566. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Hefler, C. Grimm, S. Ackermann, S. Malur, A. R. Radjabi-Rahat, S. Leodolter, M. W. Beckmann, R. Zeillinger, H. Koelbl, and C. B. Tempfer An Interleukin-6 Gene Promoter Polymorphism Influences the Biological Phenotype of Ovarian Cancer Cancer Res., June 15, 2003; 63(12): 3066 - 3068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. L. Biondi-Zoccai, A. Abbate, G. Liuzzo, and L. M. Biasucci Atherothrombosis, inflammation, and diabetes J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1071 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pola, A. Flex, E. Gaetani, R. Flore, M. Serricchio, and P. Pola Synergistic Effect of -174 G/C Polymorphism of the Interleukin-6 Gene Promoter and 469 E/K Polymorphism of the Intercellular Adhesion Molecule-1 Gene in Italian Patients With History of Ischemic Stroke Stroke, April 1, 2003; 34(4): 881 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jerrard-Dunne, M. Sitzer, P. Risley, D. A. Steckel, A. Buehler, S. von Kegler, and H. S. Markus Interleukin-6 Promoter Polymorphism Modulates the Effects of Heavy Alcohol Consumption on Early Carotid Artery Atherosclerosis: The Carotid Atherosclerosis Progression Study (CAPS) Stroke, February 1, 2003; 34(2): 402 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.H. Gomma, M.A. Elrayess, C.J. Knight, E. Hawe, K.M. Fox, and S.E. Humphries The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis Eur. Heart J., December 2, 2002; 23(24): 1955 - 1962. [Abstract] [PDF] |
||||
![]() |
N. S. Jenny, R. P. Tracy, M. S. Ogg, L. A. Luong, L. H. Kuller, A. M. Arnold, A. R. Sharrett, and S. E. Humphries In the Elderly, Interleukin-6 Plasma Levels and the -174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2066 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Athan, J. H. Lee, A. Arriaga, R. P. Mayeux, and B. Tycko Polymorphisms in the Promoter of the Human APP Gene: Functional Evaluation and Allele Frequencies in Alzheimer Disease Arch Neurol, November 1, 2002; 59(11): 1793 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Papafili, M. R. Hill, D. J. Brull, R. J. McAnulty, R. P. Marshall, S. E. Humphries, and G. J. Laurent Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1631 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Mitchison and J. Roes Patterned variation in murine MHC promoters PNAS, August 6, 2002; 99(16): 10561 - 10566. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Basso, G. D.O. Lowe, A. Rumley, A. D. McMahon, and S. E. Humphries Interleukin-6 -174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS) Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lamblin, C. Bauters, and N. Helbecque Gene polymorphisms of pro- (or anti-) inflammatory cytokines and vascular disease Eur. Heart J., December 2, 2001; 22(24): 2219 - 2220. [PDF] |
||||
![]() |
F. Basso, G. D.O. Lowe, A. Rumley, A. D. McMahon, and S. E. Humphries Interleukin-6 -174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS) Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||




























